nicht mehr verfügbar

AR10523PU-S Epstein Barr Virus mosaic EBNA1

Search for all "Epstein Barr Virus mosaic EBNA1"

Kurzübersicht

Epstein Barr Virus mosaic EBNA1

AR10523PU-S

Produktbeschreibung für Epstein Barr Virus mosaic EBNA1

Epstein Barr Virus mosaic EBNA1.
Presentation: Purified

Produktdaten von Epstein Barr Virus mosaic EBNA1

Produkt-Kategorie Proteins & Growth Factors
Menge 0.1 mg
Präsentation Purified
Source E. coli
Shipping to Worldwide
PDF datasheet Datenblatt ansehen
Hersteller OriGene Technologies GmbH
Material safety datasheet MSDS for Proteins (de)

Datenblatt-Auszug

Reinheit >95% pure as determined by 10% PAGE (coomassie staining).
Purification Method: Sepharose-Derived Purification.
Anwendung Antigen in ELISA and Western blots, excellent antigen for detection of HHV-4 (EBV)- with minimal specificity problems.
Background The Epstein-Barr virus (EBV), also called Human herpes virus 4 (HHV-4), is a virusof the herpes family (which includes Herpes simplex virusand Cytomegalo virus. On infecting the B-lymphocyte, the linear virus genome circularizes and the virus subsequently persists within the cell as an episome. The virus can execute several distinct programs of gene expressionwhich can be broadly categorized as being lytic cycle or latent cycle. The lytic cycleor productive infection results in staged expression of a host of viral proteinswith the ultimate objective of producing infectious virions. Formally, this phase of infection does not inevitably lead to lysis of the host cellas EBV virions are produced by budding from the infected cell. The latent cycle(lysogenic) programs are those that do not result in production of virions. A very limited, distinct set of viral proteins are produced during latent cycle infection. These include Epstein-Barr nuclear antigen(EBNA)-1, EBNA-2, EBNA-3A, EBNA-3B, EBNA-3C, EBNA-leader protein (EBNA-LP) and latent membrane proteins(LMP)-1, LMP-2A and LMP-2B and the Epstein-Barr encoded RNAs(EBERs).  
Concentration 1.0 mg/ml
Beschreibung
Description:
E.coli derived recombinant. The mosaic protein contains the HHV-4 EBNA regions.
Specificity: Immunoreactive with sera of EBV-infected individuals.
Format
Buffer System:
50mM Tris-HCl, 10mM Glutation, 60mM NaCl, 0.5% Sarcosyl
Purity:
>95% pure as determined by 10% PAGE (coomassie staining).
Purification Method: Sepharose-Derived Purification.
State:
Purified
  • LinkedIn